Stopping a protocol at 2 weeks because results aren't obvious means terminating during the proliferative phase before the remodeling that produces functional improvement has occurred
Unlike BPC-157, which is a synthetic fragment with no natural full-length counterpart, TB-500 mirrors an endogenous peptide with well-characterized biological roles including actin sequestration, cell migration promotion, and tissue repair coordination
None of its four peptides GHK-Cu, BPC-157, TB-500, or KPV is FDA-approved as a drug
Considerations: One downfall is that its the most expensive supplement on this list, lasting you only a few months before you need to restock
[DOI] [PubMed] [Google Scholar] 66
The problem KLOW is designed to address is fragmentation